SWX/MEDX (SWX/MEDX)

SIX Swiss Exchange: SWX/MEDX · CHF

CHF 11.1

+0.08 (+0.7%)· Recorded snapshot

Market cap	451M
Revenue (ttm)	437M
Net income (ttm)	100K
EPS (ttm)	-CHF 0.00
Shares out	40.7M
P/E (forward)	21.7x
Dividend	CHF 0.10 (0.90%)
Volume	19,687
Beta	0.79

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 437M
Net income (ttm): 100K
EPS (ttm): -CHF 0.00
P/E (forward): 21.7x
Market cap: 451M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-11-03 14:30 UTC

Forward P/E21.7

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE0.2

P25 n/aP50 n/aP75 n/a

ROIC2.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SWX/MEDX indicators

Market & fundamental data

Available fields

237

Groups with data

Currency

CHF

Showing 237 of 237 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CHF
Country	Switzerland
Country code	CH
Earnings date	2027-02-25
Employees	2,587
Employees change	13
Employees growth	0.51%
Enterprise value	CHF 666.9M
Exchange	SIX Swiss Exchange
Financial currency	CHF
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1922
Industry	Specialty Industrial Machinery
Is primary listing	Yes
ISIN number	CH1129677105
Last earnings date	2026-07-23
Last refreshed	2026-11-03
Market cap	CHF 451M
Next earnings date	2027-02-25
Price	CHF 11.08
Price currency	CHF
Sector	Industrials
SIC code	3842
Stock price date	2026-11-03
Symbol	swx/MEDX
Website	https://www.medmix.swiss

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (5Y)	558.12x
Earnings yield	-0.01%
EV/Earnings	6,636.68x
EV/EBIT	22.96x
EV/EBITDA	8.19x
EV/FCF	20.94x
EV/Sales	1.52x
FCF / EV yield	4.78%
FCF yield	7.08%
Forward P/E	21.7x
Industry forward P/E	24.96x
Industry P/E	34.11x
P/(FCF - SBC) ratio	15.77x
P/(OCF - SBC) ratio	8x
P/B ratio	1.03x
P/FCF ratio	14.13x
P/OCF ratio	7.55x
P/S ratio	1.02x
Price / tangible book value	7.34x
Price/EBITDA ratio	6.25x
Sector forward P/E	23.12x
Sector P/E	30.41x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	6.61%
EBITDA margin	16.38%
Effective tax rate	35.71%
FCF margin	7.25%
Gross margin	36.73%
Operating margin	6.61%
Pretax margin	0.32%
Profit margin	0.02%
Profit per employee	CHF 38.65
Profitable quarters	1
Profitable years	1
Revenue per employee	CHF 168,922
ROA	1.88%
ROA (5Y)	2.21%
ROCE	3.7%
ROE	0.21%
ROE (5Y)	2.54%
ROIC	2.9%
ROIC (5Y)	4.24%
SBC / revenue	0.76%
Tax / revenue	0.11%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (Q)	-93.75%
EPS growth years	1
FCF growth	-38.69%
FCF growth (Q)	-10.88%
FCF growth (QoQ)	-29.57%
FCF growth 5Y	-11.38%
Gross profit growth	-0.68%
Gross profit growth (Q)	-1.7%
Gross profit growth 3Y	1.04%
Gross profit growth 5Y	0.63%
Net income growth (Q)	-92.65%
Net income growth 3Y	-78.24%
Net income growth 5Y	-67.67%
Net income growth years	1
OCF growth	-32.92%
OCF growth (Q)	-27.96%
OCF growth (QoQ)	-41.44%
OCF growth 3Y	17.13%
OCF growth 5Y	-8.7%
Operating income growth	31.96%
Operating income growth (Q)	-0.6%
Operating income growth 3Y	11.41%
Operating income growth 5Y	-8.19%
Revenue growth	-6.64%
Revenue growth (Q)	-4.88%
Revenue growth (QoQ)	-3.68%
Revenue growth 3Y	-2.71%
Revenue growth 5Y	1.11%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CHF -27.6M
Depreciation and amortization	CHF 42.7M
EBIT	CHF 28.9M
EBITDA	CHF 71.6M
EPS	CHF -0.00
FCF per share	CHF 0.78
Financing cash flow	CHF -25.8M
Free cash flow	CHF 31.7M
Free cash flow minus SBC	CHF 28.4M
Gross profit	CHF 160.5M
Income taxes	CHF 500,000
Investing cash flow	CHF -31.7M
Net borrowing	CHF -11.2M
Net cash flow	CHF 2.7M
Net income	CHF 100,000
Operating cash flow minus SBC	CHF 56M
Operating income	CHF 28.9M
Revenue	CHF 437M
Stock-based compensation	CHF 3.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.84
Book value per share	CHF 10.44
Debt / EBITDA	3.94
Debt / equity	0.74
Debt / FCF	10.08
Goodwill	CHF 266.5M
Interest coverage	2.09
Long-term assets	CHF 682.6M
Long-term liabilities	CHF 348.8M
Net cash (debt)	CHF -208.1M
Net cash / market cap	-46.47%
Net debt / EBITDA	2.91
Net debt / equity	0.48
Net debt / FCF	6.56
Piotroski F-Score	5
Property, plant and equipment	CHF 260.9M
Shareholders' equity	CHF 432.8M
Tangible book value	CHF 61M
Tangible book value per share	CHF 1.50
Total assets	CHF 970.5M
Total cash	CHF 111.3M
Total debt	CHF 319.4M
Total liabilities	CHF 537.7M
WACC	6.18%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.45
Current assets	CHF 287.9M
Current liabilities	CHF 188.9M
Current ratio	1.52
Inventory turnover	3.44
Net working capital	CHF -700,000
Quick ratio	1.08
Working capital	CHF 99M
Working capital turnover	4.46

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-12.25%
Dividend growth	-80%
Dividend growth (3Y)	-41.52%
Dividend growth years	0
Dividend payment date	2026-04-22
Dividend payment years	5
Dividend payout frequency	Annual
Dividend per share	CHF 0.10
Dividend yield	0.9%
Ex-dividend date	2026-04-20
FCF payout ratio	12.84%
Last dividend	CHF 0.10
Payout ratio	8,700%
Shareholder yield	-11.34%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CHF 8.95
1D price change	0.73%
1M price change	12.24%
1M total return	12.24%
1W price change	6.12%
1W total return	6.12%
1Y price change	20.39%
1Y return CAGR	21.74%
1Y total return	21.73%
20-day SMA	CHF 10.22
200-day SMA	CHF 9.29
3M price change	25.57%
3M total return	25.57%
3Y price change	-40.83%
3Y return CAGR	-13.38%
3Y total return	-35.01%
50-day SMA	CHF 9.66
50-day SMA vs 200-day SMA	50over200
52-week high	CHF 12.36
52-week high date	2026-01-26
52-week low	CHF 7.61
52-week low date	2026-07-23
5Y price change	-74.48%
5Y return CAGR	-21.86%
5Y total return	-70.86%
6M price change	33.41%
6M total return	33.41%
All-time high	CHF 48.44
All-time high date	2021-12-17
All-time low	CHF 7.61
All-time low date	2026-07-23
Average true range (ATR)	CHF 0.29
Average volume	55.2K
Beta (1Y)	1.12
Beta (2Y)	1.03
Beta (5Y)	0.79
Change from 52-week high	-10.36%
Change from 52-week low	45.6%
Change from all-time high	-77.09%
Change from all-time low	45.86%
Change from open	0.73%
Day's gap	0%
Dollar volume	CHF 218,132
High price	CHF 11.14
Low price	CHF 10.74
Monthly RSI	48.12
Open price	CHF 11.00
Position in 52-week range	85%
Previous close	CHF 11.00
Price vs 150-day SMA	24.05%
Price vs 20-day SMA	8.57%
Price vs 200-day SMA	19.46%
Price vs 50-day SMA	14.91%
Relative volume	0.36
RSI	76.98
Sharpe ratio	0.66
Sharpe ratio (3Y)	-0.41
Sharpe ratio (5Y)	-0.6
Sortino ratio	1.13
Sortino ratio (3Y)	-0.39
Sortino ratio (5Y)	-0.64
Volume	19.7K
Weekly RSI	68.29
YTD price change	-1.25%
YTD total return	-0.15%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	39.3M
Shares change (QoQ)	20.34%
Shares change (YoY)	12.25%
Shares held by insiders	3.37%
Shares held by institutions	13.78%
Shares outstanding	40.7M

Deeper analysis on SWX/MEDX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SWX/MEDX report

Is a complete SWX/MEDX research report available?

No complete published report is available for swx/MEDX (SWX/MEDX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SWX/MEDX (SWX/MEDX)

Price

Financial snapshot

Fair-value bridge

Latest news · SWX/MEDX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SWX/MEDX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SWX/MEDX

Frequently asked questions